Global Human Milk Oligosaccharides Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Human Milk Oligosaccharides Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Human milk oligosaccharides are sugar molecules, that are part of the oligosaccharides group and which can be found in high concentrations exclusively in human breast milk. Human milk oligosaccharides form the third most abundant solid component of human milk after lactose and fat. HMOs are present in a concentration of 0.35 - 0.88 oz / L.

Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces

Market Overview:

The latest research study on the global Human Milk Oligosaccharides market finds that the global Human Milk Oligosaccharides market reached a value of USD 355.43 million in 2022. It’s expected that the market will achieve USD 2343.92 million by 2028, exhibiting a CAGR of 36.94% during the forecast period.

More and more applications of HMO in functional foods

Globally, people are forced to switch to functional foods such as dietary supplements and probiotics, leading to increased demand. HMOs in functional foods and beverages eliminate harmful bacteria such as Salmonella and Campylobacter and help produce good nutrition. The use of adult nutrition, such as functional foods and supplements, is increasing due to the benefits of HMO, such as improving the gut microbiota and enhancing the immune system. These factors may drive market growth during the forecast period.

High manufacturing cost

Several enzymes and chemicals used to produce human milk oligosaccharides are very expensive and have limited availability. As the price of raw materials rises, manufacturing costs increase. Not only does it cut the profit margin of the manufacturer, but it also leads to an increase in product prices. This limits the growth of the market.

Consumer health awareness and disposable income is growing

The use of HMO in dietary supplements provides benefits such as immune support, prevention of bacterial and viral infections, digestive comfort and brain function support. Increasing healthcare costs, lifestyle changes, and the growth of the elderly population are the main drivers of the food supplement industry, and consumer health awareness and disposable incomes are driving this trend. With the development of the food supplement industry, it is expected to promote the market size of human milk oligosaccharides.

Region Overview:

Geographically, USA held the largest market share – 39.15% in 2021.

Company Overview:

DSM is one of the major players operating in the Human Milk Oligosaccharides market, holding a share of 52.34% in 2022.

DSM

Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living.

Jennewein Biotechnologie

Jennewein Biotechnologie manufactures rare functional sugars for a wide range of applications, including nutritional, pharmaceutical and cosmetic products.

Segmentation Overview:

By type, Neutral segment accounted for the largest share of market in 2021.

Acidic

Acidic or sialylated HMOs: these HMOs contain sialic acid at the terminal end. Example: 2’-sialyllactose.

Neutral

Neutral or fucosylated HMOs: these HMOs contain fucose at the terminal position. Examples: 2’-fucosyllactose (2’-FL) and lactodifucopentose.

Application Overview:

The market's largest segment by application is the segment Infant Formula, with a market share of 73.09% in 2021.

Key Companies in the global Human Milk Oligosaccharides market covered in Chapter 3:

BASF
Dupont
Frieslan Campina
Glycom (DSM)
Jennewein Biotechnologie

In Chapter 4 and Chapter 14.2, on the basis of types, the Human Milk Oligosaccharides market from 2018 to 2029 is primarily split into:

Acidic
Neutral
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Human Milk Oligosaccharides market from 2018 to 2029 covers:

Food Supplements
Functional Food & Beverages
Infant Formula

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)